CHEM-X-INFINITY

Members Login Password Join Id lost? Latest news 27/09/2011 PARTNERSHIP BETWEEN CHEM-X-INFINITY AND XANCHEM CHEM-X-INFINITY partnered with XANCHEM to produce libraries around original scaffolds. The compounds will be of particular interest in the oncology field. 20/07/2011 PARTNERSHIP BETWEEN CHEM-X-INFINITY AND ORIBASE PHARMA CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have... 11/01/2011 CHEM-X-INFINITY WILL ATTEND THE 18TH MOLECULAR MEDICINE TRI-CONFERENCE CHEM-X-INFINITY will attend the 18th Molecular Medicine Tri-Conference on February 23rd-25th, 2011 in San Francisco, CA.		HOME LIBRARIES KINASE LIBRARIES GPCR LIBRARIES NUCLEOTIDE INTERACTING LIBS PEPTIDOMIMETIC LIBRARIES FRAGMENT LIBRARIES OTHER THEMES DIVERSE LIBRARIES CUSTOM LIBRARIES THE COMPANY ABOUT US PARTNERS LOCATION TERMS OF USE NEWS & PUBLICATIONS NEW LIBRARIES PRESS RELEASES FAQ ORDERING A LIBRARY QUALITY OTHER CONTACT > FAQs > ORDERING A LIBRARY > Do you provide resynthesis (more quantity of a compound of interest with purity > 95 %) ? Do you provide resynthesis (more quantity of a compound of interest with purity > 95 %) ? Yes. Since we develop our own synthesis procedures, we can provide fast resynthesis.

ARYLOXYPROPYLAMINE LIBRARY STRUCTURES FOR YOUR TARGETS AMINOPYRAZOLE LIBRARY EXPLORA2 - PYRIDINE, PYRIMIDINE & PURINE PEPTIDOMIMETIC SELECTION

Members